Among all eligible studies, 17 studies reported the correlation between EGFR expression and the prognosis of nasopharyngeal carcinoma, and there were 15, 8, 2, and 5 studies that reported OS, DFS, PFS, and DMFS as the outcome, respectively. This evidence concerns the gene EGFR and nasopharyngeal carcinoma.